DEFINITIVE PROXY

Company

Protagenic Therapeutics, Inc.\new

Filed

November 3, 1998

Period of Report

November 20, 1998

Accession Number

0000921895-98-000864

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →